4h
Investor's Business Daily on MSNDexcom Stock Makes A Recovery After Its Fourth-Quarter FumbleDexcom stock stock recovered Friday after the diabetes devices maker missed fourth-quarter profit expectations.
Much progress has been made in diabetes technology over the past decade. Continuous glucose monitoring has achieved high accuracy and reliability, resulting ...
The U.S. District Court for the Eastern District of Pennsylvania concluded the plaintiff, who has Type 1 diabetes and tracks ...
Shanghai researchers have devised a revolutionary, non-invasive method to monitor blood glucose, allowing for accurate blood ...
This CGM will track your body's response - Could personalised glucose data inform your body’s metabolism and performance?
Glucotrack has successfully completed its first in-human clinical study for the first real-time, continuous blood glucose monitor (CBGM) placed in the subclavian vein.
Gonzaga University and the UW School of Medicine hosted Irl Hirsch to lecture about the future of glucose monitoring.
Eversense 365 is the world’s first and only one year CGM, which was approved by the United States (US) Food and Drug Administration in September of 2024 and launched across the country in October of ...
Patients who use smartphone apps to manage their diabetes could face serious health problems if they miss notifications needed to control their blood sugar, U.S. health officials warned.
Continuous glucose monitors are small devices that use a sensor under the skin to measure blood sugar, sending regular ...
The use of a continuous glucose monitor during pregnancy may be more cost-effective than self-monitoring blood glucose for ...
Continuous glucose monitors, or CGMs, are small devices that track blood sugar in real time and can tell wearers how their ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results